… to the NASH population, we should consider what the appropriate therapy is for each
specific patient with NASH. The most effective pharmacologic treatments for NASH to date have …

… there is a myriad of agents … NASH will become analogous to the treatment of hypertension;
it is very likely that multiple different classes of drugs targeting different mechanistic pathways …

… pathways and review the cell-autonomous and cell-non-autonomous mechanisms by which
developmental pathways … therapeutic implications of these data for NASH and liver fibrosis. …

… myriad landmark discoveries of recent research into the pathogenic processes underlying
NASH-… related molecules in the inflammatory pathways underlying NASH-HCC progression, …

… but potentially multiple fibrogenic pathways exist in NASH, with … of NASH are aimed at the
myriad of inter-cellular mechanisms that have been implicated in the pathogenesis of NASH. …

… NAFLD and NASH are complex and reflected by the myriad of … In NASH, the developmental
pathway for therapeutic agents … as paediatric drug development pathways differ significantly. …

… often inconsistent care processes characterizing current approaches to NAFLD/NASH. The
NAFLD/NASH Clinical Care Pathway presented in this article was assembled by an expert …

… in NASH and the predominant cell death pathway in this disease [12, 22]. Apoptosis is initiated
by either membrane receptors (extrinsic pathway… consisting of a myriad of signals evoking …

… through the recognition of a myriad of danger signs known as … plays an important role in
NASH progression. Recent studies … In addition to these pathways, patients with NASH reveal …

… the impairment of many metabolic pathways, including decreased … for the treatment of NASH,
we discuss pharmacological … They also have a myriad of other beneficial metabolic effects, …